ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.155
-0.15%
Bitcoin
67,276.29
-1.31%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Artelo Biosciences Inc (ARTL)

  7. Artelo Biosciences Inc (ARTL) News

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateTimeSourceHeadlineSymbolCompany
07/15/20248:30AMGlobeNewswire Inc.Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 InhibitorNASDAQ:ARTLArtelo Biosciences Inc
07/03/20249:00AMGlobeNewswire Inc.Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
07/02/20249:00AMGlobeNewswire Inc.Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor PlatformNASDAQ:ARTLArtelo Biosciences Inc
07/01/20249:00AMGlobeNewswire Inc.Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
06/04/20248:30AMGlobeNewswire Inc.Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain SocietyNASDAQ:ARTLArtelo Biosciences Inc
05/29/20248:30AMGlobeNewswire Inc.Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24NASDAQ:ARTLArtelo Biosciences Inc
05/13/20248:00AMGlobeNewswire Inc.Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
05/10/20249:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thNASDAQ:ARTLArtelo Biosciences Inc
04/23/20248:30AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
04/22/20248:30AMGlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
03/25/20248:00AMGlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
03/12/20249:15AMGlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
01/23/20248:30AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
01/08/20248:30AMGlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
12/05/20238:30AMGlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
11/30/20239:00AMGlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
11/13/20238:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
11/13/20238:00AMGlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
11/09/20239:00AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
11/02/20238:30AMGlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
10/04/20238:30AMGlobeNewswire Inc.Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaNASDAQ:ARTLArtelo Biosciences Inc
09/13/20238:30AMGlobeNewswire Inc.Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thNASDAQ:ARTLArtelo Biosciences Inc
09/07/20238:00AMGlobeNewswire Inc.Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12NASDAQ:ARTLArtelo Biosciences Inc
09/06/20239:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thNASDAQ:ARTLArtelo Biosciences Inc
09/05/20239:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thNASDAQ:ARTLArtelo Biosciences Inc
08/10/20238:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
08/10/20238:00AMGlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
08/08/20234:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
08/08/20234:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
07/19/20239:00AMGlobeNewswire Inc.Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023NASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
NSAV
Net Savings Link (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved